Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Artemis Medicare Services Ltd (ARTEMISMED)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542919 NSE: ARTEMISMED Hospital & Healthcare Services | Small Cap | Artemis MedicareServ Share Price
₹329.65 -14.75 (-4.28%)
As on 15-Sep'26 16:59
Artemis Medicare Services Ltd (ARTEMISMED)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 542919 NSE: ARTEMISMED Hospital & Healthcare Services | Small Cap | Artemis MedicareServ Share Price
₹329.65 -14.75 (-4.28%)
As on 15-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹5,452 Cr.
Current Price
₹329.7
52-Week Low / High
₹203 / 362
TTM EPS
₹7.2
TTM Sales
₹1,114 Cr.
Book Value per Share
₹56.7
P/E Ratio
47.97
Higher than its 5-year historical median
Industry PE
99.8
Price to Book (P/B)
6.08
Higher than its 5-year historical median
Price to Sales (P/S)
4.90
Higher than its 5-year historical median
EV/EBITDA
23.64
Higher than its 5-year historical median
Dividend Yield
0.14%
Profitability Efficiency
Return on Equity (ROE)
12.72%
Outperforms industry median
Return on Capital Employed (ROCE)
15.83%
In line with industry median
Return on Assets (ROA)
7.14%
Operating Profit Margin
17.4%
Net Profit Margin
9.59%
Gross Profit Margin
17.6%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
16.12%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
23.97%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
26.21%
Asset Quality
Promoter Holding
58.39%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹881 Cr.
Equity
₹15.8 Cr.
Face Value
₹1
All Time Low / High
₹12.00 / 361.50
Check Before You Invest
Quality
Somewhat GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Strong
Is Artemis Medicare Services Ltd a good quality company?
Artemis Medicare Services Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Artemis Medicare Services Ltd performance compare with that of its Peers?
Revenue growth of Artemis Medicare Services Ltd vs industry peers?
Artemis Medicare Services Ltd revenue CAGR is 21.50%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Artemis Medicare Services Ltd?
Promoters hold 58.39% of the Artemis Medicare Services Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Artemis Medicare Services Ltd over the last decade?
Over the last 5 year(s), the stock has delivered a CAGR of 54.95% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Artemis Medicare Services Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 20.6% | 18.4% | 16.1% | 13% | 5.9% | 11.9% | 13.9% | 16.5% | 17.1% | 15.7% | - |
| Value Creation Index ⓘ | 0.5 | 0.4 | 0.2 | -0.1 | -0.6 | -0.2 | 0.0 | 0.2 | 0.2 | 0.1 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 459 | 503 | 547 | 563 | 402 | 545 | 714 | 845 | 913 | 1,060 | 1,093 |
| Sales YoY Gr. | - | 9.5% | 8.7% | 3% | -28.6% | 35.5% | 31.1% | 18.3% | 8.1% | 16.1% | - |
| Adj EPS ⓘ | 1.3 | 1.3 | 0 | 1.5 | 0.4 | 2.5 | 2.8 | 3.6 | 6 | 6.6 | 7.1 |
| YoY Gr. | - | 0% | -100% | NA | -75.7% | 583.3% | 15.5% | 25.7% | 69.2% | 9.6% | - |
| BVPS (₹) ⓘ | 6.6 | 7.9 | 0 | 18.7 | 19.3 | 21.7 | 24.7 | 27.8 | 55.9 | 54.9 | 56.9 |
| Adj Net Profit ⓘ | 26.9 | 27 | 21.9 | 19.6 | 4.8 | 32.6 | 38.1 | 48.5 | 83 | 105 | 113 |
| Cash Flow from Ops. ⓘ | 57.9 | 71.9 | 40.5 | 56.5 | 27 | 60.7 | 129 | 108 | 150 | 129 | - |
| Debt/CF from Ops. ⓘ | 1.6 | 1.3 | 2.8 | 1.6 | 4.4 | 2.9 | 1.7 | 2.2 | 1.6 | 1.8 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 9.8% | 21.4% | 14.1% | 16.1% | ||||
| Adj EPS ⓘ | 20% | 79% | 32.6% | 9.6% | ||||
| BVPSⓘ | 26.5% | 23.3% | 30.6% | -1.8% | ||||
| Share Price | - | 54.7% | 34.6% | 36.5% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 13.9 | 12.4 | 8.3 | 6.4 | 1.5 | 9.5 | 9.9 | 11.3 | 12.8 | 11.8 | 12.8 |
| Op. Profit Mgn % ⓘ | 11.5 | 12 | 12.1 | 11.1 | 8.8 | 12.2 | 13.2 | 15.2 | 16.4 | 17.5 | 18.3 |
| Net Profit Mgn % ⓘ | 5.9 | 5.4 | 4 | 3.5 | 1.2 | 6 | 5.3 | 5.7 | 9.1 | 9.9 | 10.3 |
| Debt to Equity ⓘ | 0.7 | 0.6 | 0.5 | 0.4 | 0.5 | 0.6 | 0.7 | 0.6 | 0.3 | 0.3 | - |
| Working Cap Days ⓘ | 76 | 69 | 67 | 76 | 106 | 85 | 79 | 74 | 76 | 115 | 72 |
| Cash Conv. Cycle ⓘ | -4 | -7 | -4 | 2 | 4 | 5 | 5 | -2 | -5 | -0 | 35 |
Valuation of Artemis MedicareServ - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 44.53 | 44.53 | 44.53 | 44.53 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 547 | 565 | 408 | 555 | 737 | 879 | 937 | 1,081 |
| Operating Expenses ⓘ + | 483 | 504 | 373 | 488 | 643 | 746 | 785 | 893 |
| Operating Profit ⓘ | 64 | 61 | 35 | 66 | 94 | 133 | 152 | 188 |
| Operating Profit Margin (%) | 11.7% | 10.9% | 8.6% | 12.0% | 12.7% | 15.1% | 16.2% | 17.4% |
| Other Income ⓘ + | 4 | 5 | 4 | 5 | 7 | 7 | 33 | 30 |
| Interest ⓘ | 11 | 13 | 13 | 12 | 20 | 31 | 32 | 28 |
| Depreciation ⓘ | 20 | 23 | 22 | 22 | 31 | 40 | 45 | 48 |
| Profit Before Tax ⓘ | 37 | 31 | 8 | 37 | 51 | 68 | 108 | 139 |
| Tax ⓘ | 16 | 11 | 1 | 6 | 13 | 19 | 25 | 35 |
| Profit After Tax | 20 | 19 | 6 | 31 | 38 | 49 | 82 | 104 |
| PAT Margin (%) | 3.7% | 3.4% | 1.5% | 5.7% | 5.2% | 5.6% | 8.8% | 9.6% |
| Adjusted EPS (₹) | 0.0 | 1.5 | 0.5 | 2.4 | 2.9 | 3.6 | 6.0 | 6.6 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 15.60% | 12.40% | 7.50% | 6.90% |
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 280 | 313 | 320 | 352 | 395 | 442 | 834 | 935 | |||
| Debt + | 91 | 76 | 108 | 161 | 214 | 228 | 209 | 190 | |||
| Minority Interest | -0 | 0 | 2 | 2 | 5 | 6 | 6 | 6 | |||
| Trade Payables | 74 | 75 | 57 | 60 | 88 | 95 | 101 | 98 | |||
| Others Liabilities ⓘ | 109 | 122 | 122 | 151 | 229 | 231 | 249 | 278 | |||
| Total Liabilities ⓘ | 554 | 586 | 609 | 726 | 930 | 1,002 | 1,399 | 1,508 | |||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 381 | 393 | 383 | 489 | 605 | 719 | 745 | 804 | |||
| CWIP ⓘ | 49 | 56 | 81 | 64 | 95 | 33 | 40 | 29 | |||
| Investments ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
| Inventories | 7 | 11 | 10 | 12 | 14 | 10 | 10 | 13 | |||
| Trade Receivables | 79 | 77 | 55 | 73 | 93 | 95 | 101 | 120 | |||
| Cash Equivalents | 12 | 16 | 31 | 28 | 51 | 61 | 396 | 206 | |||
| Others Assets ⓘ | 26 | 34 | 49 | 60 | 72 | 83 | 108 | 335 | |||
| Total Assets ⓘ | 554 | 586 | 609 | 726 | 930 | 1,002 | 1,399 | 1,508 | |||
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 40 | 56 | 27 | 60 | 127 | 109 | 156 | 132 |
| Cash Flow From Investing Activity ⓘ + | -50 | -26 | -37 | -107 | -158 | -88 | -393 | -90 |
| Cash Flow From Financing Activity ⓘ + | 14 | -27 | 18 | 44 | 38 | -29 | 264 | -50 |
| Net Cash Flow ⓘ | 5 | 2 | 8 | -3 | 7 | -8 | 27 | -8 |
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 9.5 | 8.43 | 2.46 | 11.66 | 12.41 | 14.01 | 14.43 | 12.72 | ||
| ROCE (%) | 13.96 | 12.64 | 5.63 | 11.47 | 13.34 | 16.47 | 16.93 | 15.83 | ||
| Asset Turnover Ratio | 0.99 | 0.99 | 0.68 | 0.83 | 0.89 | 0.91 | 0.78 | 0.74 | ||
| PAT to CFO Conversion(x) | 2 | 2.95 | 4.5 | 1.94 | 3.34 | 2.22 | 1.9 | 1.27 | ||
| Working Capital Days | ||||||||||
| Receivable Days | 52.50 | 50.10 | 58.70 | 42.20 | 41.30 | 39.10 | 38.20 | 37.30 | ||
| Inventory Days | 4.60 | 5.70 | 9.10 | 7.20 | 6.50 | 5 | 3.90 | 4 | ||
| Payable Days | 206 | 194.90 | 206.70 | 138 | 141.50 | 152.50 | 157 | 143.50 | ||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Artemis Medicare Services Ltd FAQs
The current trading price of Artemis MedicareServ on 15-Sep-2026 16:59 is ₹329.6.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 14-Sep-2026 the market cap of Artemis MedicareServ stood at ₹5,452.1 Cr
The latest P/E ratio of Artemis MedicareServ as of 14-Sep-2026 is 48.22.
The latest P/B ratio of Artemis MedicareServ as of 14-Sep-2026 is 6.05.
The 52-week high of Artemis MedicareServ is ₹361.5 and the 52-week low is ₹202.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Artemis MedicareServ is ₹1,093 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Artemis Medicare Services Ltd is a average quality company.
The key valuation ratios of Artemis Medicare Services Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Artemis Medicare Services Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Artemis Medicare Services Ltd
Artemis Medicare Services Limited was incorporated on May 18, 2004. The Company commenced its commercial operation by setting up Artemis Hospital (formerly Artemis Health Institute) at Gurugram on 16th July, 2007.
Artemis Health Institute, established in 2007, is a healthcare venture launched by the promoters of the Apollo Tyres Group. Artemis is the first Hospital in Gurgaon to get accredited by Joint Commission International (JCI) (in 2013). It is the first Hospital in Haryana to get NABH accreditation within 3 years of start up.
Designed as one of the most advanced in India, Artemis provides a depth of expertise in the spectrum of advanced medical & surgical interventions, comprehensive mix of inpatient and outpatient services. Artemis has put modern technology in the hands of renowned from across the country and abroad to set new standards in healthcare. The medical practices and procedures followed in the hospital are research oriented and benchmarked against the best in the world. Top-notch services, in a warm, open centric environment, clubbed with affordability, has made it one of the most revered hospitals in the country.
Business area of the company
The Company is engaged in the business of managing and operating of multi specialty hospitals.
Awards
- 2020: First position in CII National HR Circle Competition (Stream: Innovative Leadership during Crisis)by Confederation of Indian Industry (CII)
- 2019: Kayakalp Award for Excellence in promoting cleanliness, hygiene and infection control by Quality Council of India in association with Ministry of Health and Family Welfare, Government Of India
- 2019: Healthcare HR Excellence Award by Rxcruit
- 2019: Indian Healthcare Excellence Awardby Brands Win
- 2019: Excellence in Healthcare Award at “India’s Most Trusted Healthcare Awards 2019” (Best Bone Marrow Transplant Centre in North India) by My Brand Better
- 2019: One of India's Top 50 Companies with GPMS (Great People Managers Study) by Great Manager Institute in association with Forbes India
- 2019: D.L. Shah Quality Silver Award - For the case study End to End Care Delivery by Quality Council of India
- 2018: FICCI Healthcare Excellence Award 2018 for Service Excellence by FICCI Healthcare
- 2018: Award for Excellence in Healthcare by The Healthcare Today
- 2018: Best Multi Super Specialty Hospital in Delhi NCR by Health Care Awards
- 2017: Best Super Specialty Hospital in Delhi - NCR by Indian Excellence Award 2017
- 2017: Best Hospital in Quality Treatment - State Health Awards by IMA Punjab & AHPI
- 2017: Healthcare Transformation Awards - Mobile Innovations in healthcare by NASSCOM dynamic CIO.
You have 45 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
